Skip to content
No other fees Fully open access

Регуляторные исследования и экспертиза лекарственных средств

Regulatory Research and Medicine Evaluation

Published by Federal State Budgetary Institution ‘Scientific Centre for Expert Evaluation of Medicinal Products’ of the Ministry of Health of the Russian Federation (FSBI ‘SCEEMP’) in Russian Federation

Visit journal Author guidelines Report a correction

Summary and key facts

Регуляторные исследования и экспертиза лекарственных средств is a peer-reviewed open access journal that charges authors no article processing charge (APC). It is published by Federal State Budgetary Institution ‘Scientific Centre for Expert Evaluation of Medicinal Products’ of the Ministry of Health of the Russian Federation (FSBI ‘SCEEMP’) in Russian Federation. Its ISSN is 3034-3453 (online) and 3034-3062. It uses double anonymous peer review. It is indexed in Crossref and Google Scholar. Articles are published under a CC BY licence and authors retain copyright without restriction. The journal charges no other fees such as submission or page charges.

Article processing charge
None — free to publish
Open access
Yes, fully open access
ISSN (online)
3034-3453
ISSN (print)
3034-3062
Publisher
Federal State Budgetary Institution ‘Scientific Centre for Expert Evaluation of Medicinal Products’ of the Ministry of Health of the Russian Federation (FSBI ‘SCEEMP’)
Country
Russian Federation
Peer review
Double anonymous peer review
Licence
CC BY
Time to publication
8 weeks (average)
Open access since
2024
Articles indexed
539
Indexed in
Crossref, Google Scholar
Other fees
None
Waiver policy
Not applicable (no fees charged)

Indexing and abstracting

Recorded coverage for this journal. Verify with each database before relying on it for a research assessment exercise.

Policies and practices

What this journal publicly states about its own practices. Links go to the journal's own statements.

Peer review
Double anonymous peer review
Plagiarism screening
Yes
Licence
CC BY
Author retains copyright
Yes
Machine-readable licensing
Yes
Persistent identifiers
DOI
Deposit policy
Preprint and Postprint Deposition
Fully open access (no embargo)
Yes
Average time to publication
8 weeks
Open access since
2024

Charges to authors

Article processing charge
None
This journal does not charge an APC.
Other fees
None
No submission, page or colour charges recorded.

Fee policies change. Always confirm on the journal's own website before submitting.

Frequently asked questions

Does Регуляторные исследования и экспертиза лекарственных средств charge an article processing charge?

No. Регуляторные исследования и экспертиза лекарственных средств charges authors no article processing charge (APC). It also records no other fees such as submission or page charges.

Is Регуляторные исследования и экспертиза лекарственных средств peer reviewed?

Yes. Регуляторные исследования и экспертиза лекарственных средств uses double anonymous peer review. A documented peer review process is required for a journal to be listed in this directory.

Where is Регуляторные исследования и экспертиза лекарственных средств indexed?

Регуляторные исследования и экспертиза лекарственных средств is recorded in this directory as indexed in Crossref and Google Scholar. Indexing coverage changes over time, so verify current status with the indexing database before relying on it.

How long does it take to publish in Регуляторные исследования и экспертиза лекарственных средств?

Регуляторные исследования и экспертиза лекарственных средств reports an average of 8 weeks between submission and publication. Actual timelines vary by manuscript and review outcome.

Similar journals with no APC

Other journals covering the same subjects.